Arnuity Ellipta · DIN 02446588 · 200 mcg · Blister dry-powder inhaler, 30 doses
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Arnuity Ellipta · DIN 02446588
Manufacturer: GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care; listing date 2016-09-29
Health Canada: Marketed since 2015-12-14 · brand ARNUITY ELLIPTA · ATC R03BA09 FLUTICASONE FUROATE · form Powder · route Oral, Inhalation · ingredients FLUTICASONE FUROATE 200 MCG/ACT · company Glaxosmithkline inc · schedule Prescription
Arnuity Ellipta: Formulary list price $103.52 per unit (the source does not state the unit; exact figure $103.5200). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02446588)
Source record
DIN 02446588: Arnuity Ellipta
Raw flags: sec3=Y
Item: 680400112; group id 710; item number 1751; lccId None; manufacturer id GSK
Source form: Blister Pd Inh-30 Dose Pk; strength: 200mcg
Recorded listing: General benefit
Source prices (unrounded): $103.5200; ministry $103.5200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02446588
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93201
Shortage status: not checked (no credentials)